Interim Results
Oxford Instruments PLC
13 November 2001
13 November 2001
Oxford Instruments plc
Announcement of interim results for 2001/02
Oxford Instruments plc, the advanced instrumentation group, today announced
consolidated interim results for the half year to September 2001.
* Orders for the wholly-owned businesses increased by 2% on the first half
last year to £94 million.
* Turnover for the wholly-owned businesses up by 35% to £104 million.
* Operating profit for the wholly-owned businesses increased to £2.4
million, compared with a loss of £1.4 million for the first half last
year.
* Pre-tax profits increased to £6.1 million (2000 £0.5 million) including
£2.7 million from the share of the OMT joint venture operating profit and
£1.8 million from the sale of a surplus property.
* Net borrowings were £11.3 million, a net £3 million outflow during the
period.
* Interim dividend is held at 2.4 pence.
Andrew Mackintosh, Chief Executive said: ' I am pleased to be able to report a
further substantial improvement in our financial performance over the past six
months as forecast. This reflects material progress in the operational
efficiency of our businesses as a result of major reorganisation over the past
two years. We are approaching the future with confidence, given that our
technical strength allied to increasingly effective execution will enable us
to compete successfully in our markets.'
Enquiries: Oxford Instruments plc Tel: 01865 881437 Fax: 01865 881944
Nigel Keen, Chairman
Andrew Mackintosh, Chief Executive
Martin Lamaison, Financial Director
Citigate Dewe Rogerson Tel: 020 7638 9571 Fax: 020 7282 8190
Chris Barrie
No. of pages: 12
For further copies of this Interim Results announcement please contact
Vinnetta Hutchings at the Company's registered office at Old Station Way,
Eynsham, Witney Oxon OX29 4TL (email: vinnetta.hutchings@oxinst.co.uk).
Chairman's Statement
Nigel Keen, Chairman of Oxford Instruments plc, said today:
'The encouraging financial results for the last 6 months have been achieved
following the restructuring programme carried out over the past two years.
Orders for the period of £94 million (2000 £92 million) from the wholly-owned
businesses held up well, increasing by 2% over the same period last year.
Orders from the markets for research products were particularly strong,
counteracting weakness in the semiconductor and other industrial segments.
Turnover of £104 million for the period was 35% higher (2000 £77 million),
reflecting further material progress in reducing the high order backlog and
improving operational efficiency.
Pre-tax profits before exceptional items increased to £4.3 million (2000 £0.9
million). This comprised a £3.8 million improvement in operating profit of the
wholly-owned businesses to £2.4 million (2000 £1.4 million loss), with a
contribution of £2.7 million (2000 £2.5 million) from the share of the
operating profits of Oxford Magnet Technology (OMT), our joint venture with
Siemens. Interest payable was £0.8 million. In total, pre-tax profits for the
period were £6.1 million (2000 £0.5 million), which included an exceptional
profit of £1.8 million from the sale of a surplus property following the
restructuring.
Net borrowings at the half-year were £11.3 million, reflecting a net cash
outflow of £3.0 million in the period. This included an increase in working
capital as a result of higher turnover offset by the receipt of £3.0 million
from the sale of the property.
The Directors have recommended an interim dividend of 2.4p, unchanged from
last year.
Operational review
Analytical
Turnover for the period increased by 58% to £44 million (2000 £28 million),
reflecting the delivery to customers of a substantial proportion of the record
orders received in the second half of last year. Operating profits moved
forward strongly to £4.1 million (2000 £0.4 million). However, as forecast,
the rate of receipt of new orders in the period is 18% down on the average for
last year, reflecting the slowdown in orders from the semiconductor industry
and a continuing general weakness in the American market.
We have recently launched a major new hardware platform for our market-leading
'INCA' chemical analysis product. The reduced size and modern design of this
unit is easier to manufacture and allows more effective integration with our
customers' equipment.
We announced on 29 October 2001 the acquisition of the assets of USA-based CMI
International for $2.2 million, a market-leader in the measurement of thin
metallic coatings for a range of industrial applications. This business
complements our existing product lines serving industrial quality control
markets.
Medical
Despite stable orders and increased turnover of £19 million (2000 £17
million), losses of £0.8 million (2000 £0.9 million loss) were incurred in the
period. As a result of this, changes to the management and structure of
operations have been made to improve capacity and efficiency going forward.
Investment in the future continues both through new products and the creation
of new alliances to broaden our range of products and sales channels. We
recently brought to market in record time a significant new software product
which aids the diagnosis of the health of a baby during late pregnancy. This
will contribute to our growing instrument sales into the obstetrics sector,
supporting our new 'FM800' fetal monitor, which is now selling well.
Superconductivity
Turnover grew by 27% on the same period last year to £41 million (2000 £32
million), reflecting continuing good progress in increasing capacity and
successfully completing a number of technically demanding but low-margin
projects.
We have made further encouraging progress with the limited number of 'legacy
contracts' which continue to slow down the recovery of this business. One key
project has been delivered successfully during the period, while good
technical and commercial progress has been made on two others. There remains
however substantial technical risk in these projects until they are complete.
Our US-based wire and MRI magnet service business continues to perform well,
supplying increased volumes of wire to MRI magnet businesses. Customers have
recently used our unique wire product to produce the world's most intense
magnetic field in a magnet which could be used in significant volumes by the
next generation of particle accelerators.
The loss for the period of £0.9 million (2000 £0.9 million loss) was in line
with internal recovery forecasts, reinforcing our confidence that investment
over the past two years in project management and other process improvement is
paying off. Trading is expected to improve in the second half of the year as
we commence deliveries to customers of our world-leading 'Discovery' magnets
used for drug development.
Oxford Magnet Technology
The 49% share of OMT, our joint venture with Siemens, generated operating
profits for the period of £2.7 million (2000 £2.5 million) on turnover up 18%
on the equivalent period last year. Pricing pressure is likely in the future
to be intensified by recent consolidation in the customer base for OMT's
products.
Discussions continue with Siemens over the future of OMT beyond the initial
term of the joint venture which ends in September 2004. Siemens, who is also
the principal customer of the business, expects to increase its shareholding
in OMT under any future arrangement. We have not yet been able to agree a
revised financial structure for the relationship after 2004 which reflects the
interests of our shareholders.
Board change
Richard Wakeling decided to step down from the Board in September 2001 after 6
years as a non-executive director. He has provided valuable advice and support
to the Company during the major changes over the past few years. We wish him
well with his future plans.
Prospects
The priority for the business remains to achieve further improvement in
operational efficiency and we expect additional material progress over the
next few months. We continue to focus on initiatives that improve the standard
of our service to customers through the timely delivery of high quality
products.
Turnover in the second half of the year is expected to remain at current
levels as increased shipments from the high order backlog in our Medical and
Superconductivity businesses offset the expected reduction in turnover from
our Analytical business. Our objective moving into next year is to ensure that
all businesses are operating with reduced delivery times to customers so that
we can compete aggressively for increased shares of the markets we serve.'
Group Profit and Loss Account
Half year ended 30 September 2001 - unaudited
Half year to 30 September 2001
Continuing Exceptional Total
operations items
Notes £000 £000 £000
Turnover
Group and share of joint venture 1 126,751 - 126,751
turnover
Less share of joint venture turnover 3 (22,692) - (22,692)
Group turnover 2 104,059 - 104,059
Cost of sales (72,613) - (72,613)
Gross profit 31,446 - 31,446
Net operating expenses (29,016) - (29,016)
Group operating profit 2 2,430 - 2,430
Share of operating profit of joint 3 2,657 - 2,657
venture
Total operating profit
Group and share of joint venture 5,087 - 5,087
Profit on disposal of property - 1,826 1,826
Profit before interest 5,087 1,826 6,913
Total net interest payable (784) - (784)
Profit on ordinary activities before 4,303 1,826 6,129
tax
Tax on profit on ordinary activities 6 (1,597) - (1,597)
Profit for the period attributable 7 2,706 1,826 4,532
to shareholders
Dividends 8 (1,126)
Retained profit for the period 3,406
pence Pence pence
Earnings per share - basic and 7 5.8 3.9 9.7
diluted
Group Profit and Loss Account
Half year ended 30 September 2000 - unaudited
Half year to 30 September 2000 Year to
As restated 31
March
Continuing Exceptional Discontinue Total 2001
operations items operations
As
restated
Notes £000 £000 £000 £000 £000
Turnover
Group and 1 96,535 - 1,511 98,046 221,910
share of
joint
venture
turnover
Less share 3 (19,525) - - (19,525) (36,775)
of joint
venture
turnover
Group 2 77,010 - 1,511 78,521 185,135
turnover
Cost of (54,524) (157) (1,427)(56,108) (133,845)
sales
Gross profit 22,486 (157) 84 22,413 51,290
/(loss)
Net (23,838) (607) (740)(25,185) (52,642)
operating
expenses
Group 2 (1,352) (764) (656) (2,772) (1,352)
operating
loss
Share of 3 2,483 - - 2,483 4,350
operating
profit of
joint
venture
Total
operating
profit/
(loss)
Group and 1,131 (764) (656) (289) 2,998
share of
joint
venture
Profit on 5 - - 1,010 1,010 599
sale of
discontinued
business
Profit/ 1,131 (764) 354 721 3,597
(loss)
before
interest
Total net (184) - - (184) (792)
interest
payable
Profit/ 947 (764) 354 537 2,805
(loss) on
ordinary
activities
before tax
Tax on 6 (220) 22 24 (174) (2,869)
profit/
(loss) on
ordinary
activities
Profit/ 7 727 (742) 378 363 (64)
(loss) for
the period
attributable
to
shareholders
Dividends 8 (1,131) (3,942)
Retained (768) (4,006)
loss for the
period
pence pence pence pence pence
Earnings/ 7 1.6 (1.6) 0.8 0.8 (0.1)
(losses) per
share -
basic and
diluted
Group Statement of Total Recognised Gains and Losses
Half year ended 30 September 2001 - unaudited
Half Half Year
year to year to to
30 Sep 30 Sep 31 Mar
2001 2000 2001
As As
restated restated
Notes £000 £000 £000
Profit/(loss) for the period 4,532 363 (64)
Exchange differences on foreign currency net (1,172) 2,335 3,656
investments of the Group
Total recognised gains and losses relating to 3,360 2,698 3,592
the period
Prior year adjustments 1 2,841
Total gains and losses recognised since last
Annual Report
6,201
Group Balance Sheet
Half year ended 30 September 2001 - unaudited
As As As
at at at
30 Sep 30 Sep 31 Mar
2001 2000 2001
As As
restated restated
Notes £000 £000 £000
Fixed assets
Goodwill 4,927 2,581 5,341
Negative goodwill (664) (1,195) (930)
Intangible assets 4,263 1,386 4,411
Tangible assets 42,221 40,388 43,731
Investments
Share of gross assets of joint venture 16,350 14,599 15,937
Share of gross liabilities of joint (11,926) (9,278) (13,176)
venture
Net investment in joint venture 4,424 5,321 2,761
Other investments 2,154 1,247 2,260
Total investments 6,578 6,568 5,021
Total fixed assets 53,062 48,342 53,163
Current assets
Stocks 48,631 42,653 43,696
Debtors 64,007 64,803 69,338
Cash at bank and in hand 3,776 3,000 1,643
116,414 110,456 114,677
Creditors: amounts falling due within
one year
Bank loans and overdrafts (15,079) (8,466) (9,959)
Other creditors (56,317) (51,839) (61,933)
(71,396) (60,305) (71,892)
Net current assets 45,018 50,151 42,785
Total assets less current liabilities 98,080 98,493 95,948
Provisions for liabilities and charges (6,076) (6,806) (6,178)
Net assets employed 92,004 91,687 89,770
Capital and reserves
Called up share capital 2,392 2,392 2,392
Share premium account 18,656 18,656 18,656
Other reserves 15,930 15,930 15,930
Profit and loss account 55,026 54,709 52,792
Equity shareholders' funds 9 92,004 91,687 89,770
Group Cash Flow Statement
Half year ended 30 September 2001 - unaudited
Half Half Year
year to year to to
30 Sep 30 Sep 31 Mar
2001 2000 2001
Notes £000 £000 £000
Net cash outflow from operating activities 10 (3,085) (9,350) (1,925)
Dividend from joint venture - - 3,691
Returns on investments and servicing of 10 (546) (54) (432)
finance
Taxation 426 1,914 (250)
Capital expenditure and financial investment 10 284 (1,990) (6,229)
Acquisitions - - (3,911)
Disposals - 1,356 1,983
Equity dividends paid - - (3,953)
Cash outflow before management of liquid (2,921) (8,124) (11,026)
resources and financing
Management of liquid resources 10 2,000 4,997 9,500
Decrease in cash in the period (921) (3,127) (1,526)
Reconciliation of Net Cash Flow to Movement in Net Debt
Half year ended 30 September 2001 - unaudited
Half year Half year Year
to to to
30 Sep 30 Sep 31 Mar
2001 2000 2001
Notes £000 £000 £000
Decrease in cash in the (921) (3,127) (1,526)
period
Change in liquid resources (2,000) (4,997) (9,500)
Translation difference (66) 54 106
Movement in net funds in the (2,987) (8,070) (10,920)
period
Opening net (debt)/funds (8,316) 2,604 2,604
Closing net debt 11 (11,303) (5,466) (8,316)
Notes on the Interim Financial Statements
Half year ended 30 September 2001 - unaudited
1. Basis of presentation of accounts
The Group profit and loss account and balance sheet for the half years ended
30 September 2001 and 30 September 2000 have been prepared on a basis
consistent with the accounting policies disclosed in the Group's Report and
Accounts 2001, subject to the application of FRS 19 as discussed below.
Discontinued operations include the cathodoluminescence and accessories
business sold in June 2000, together with the operations of the Accelerator
Technology Group including the beamlines business sold in January 2001.
The Group has adopted FRS 19 'Deferred Tax' in the period, resulting in the
restatement of prior periods' profit and loss accounts, balance sheets and
statements of recognised gains and losses. Application of the standard has
resulted in the creation of a deferred tax asset of £2.8 million (£3.0 million
at 30 September 2000 and 31 March 2001) in respect of timing differences and
has required the restatement of goodwill on the recognition of deferred tax
assets in an acquired company.
The principal exchange rates used to translate the Group's overseas results
were as follows:
Half year to Half year to Year to
30 Sep 2001 30 Sep 2000 31 Mar 2001
Average Period End Average Period End Average Period End
US Dollar 1.43 1.47 1.52 1.48 1.48 1.42
Euro 1.62 1.61 1.64 1.68 1.64 1.61
Yen 175 175 162 160 164 178
2. Results by business group for continuing operations
Turnover Operating profit/(loss)
Half year to Half year to Half year to Half year to
30 Sep 2001 30 Sep 2000 30 Sep 2001 30 Sep 2000
£000 £000 £000 £000
Analytical 43,534 27,581 4,142 381
Medical 19,169 16,934 (849) (874)
Superconductivity 41,356 32,495 (863) (859)
104,059 77,010 2,430 (1,352)
Share of OMT jv (49%) 22,692 19,525 2,657 2,483
126,751 96,535 5,087 1,131
Notes on the Interim Financial Statements (Continued)
3. Joint venture
The Group owns 49% of the issued share capital of Oxford Magnet Technology
Limited (OMT). It is engaged in advanced instrumentation and is registered and
operates in England. The Group has accounted for its interest in OMT as a
joint venture.
The Group's share of the joint venture turnover as shown in the Group profit
and loss account has been derived after adjusting for trading between the
Group and OMT as follows:
Half year to Half year to
30 Sep 2001 30 Sep 2000
£000 £000
49% of joint venture turnover 29,027 24,494
Less 49% of sales by OMT to Group (3,468) (2,193)
Less 49% of sales by Group to OMT (2,867) (2,776)
Group share of joint venture turnover 22,692 19,525
4. Exceptional Items
Exceptional items for the period to 30 September 2000 related to continuing
activities and included the costs incurred in connection with the
reorganisation of the Group's UK based businesses.
5. Disposal of businesses
In the period to 30 September 2000 the Group sold its cathodoluminescence and
accessories business for a cash consideration of £1.4 million. There was a net
profit on disposal of £1.0 million. There were no disposals in the period to
30 September 2001.
6. Taxation
The tax charge for the half year ended 30 September 2001 has been based on the
estimated effective rate applicable to each significant category of income for
the full year.
7. Earnings per share
Earnings per share (EPS) has been calculated using profits of £4,532,000 (2000
£363,000) and weighted average shares of 46,929,456 (2000 47,109,456) for
basic EPS and 46,972,248 (2000 47,113,498) for diluted EPS respectively.
8. Dividends per share
An interim dividend of 2.4p (2000 2.4p) will be paid on 22 March 2002 to
shareholders registered at the close of business on 22 February 2002, the
record date. The shares will be marked 'ex-dividend' on 20 February 2002.
Notes on the Interim Financial Statements (Continued)
9. Movements in Equity Shareholders' Funds
Half Half year Year
year to to to
30 Sep 30 Sep 31 Mar
2001 2000 2001
As As
restated restated
£000 £000 £000
Profit/(loss) for the period 4,532 363 (64)
Dividends paid and proposed (1,126) (1,131) (3,942)
Retained profit/(loss) for the period 3,406 (768) (4,006)
Exchange differences on foreign currency net (1,172) 2,335 3,656
investments
Net increase/(reduction) in equity 2,234 1,567 (350)
shareholders' funds
Opening equity shareholders' funds 89,770 90,120 90,120
Closing equity shareholders' funds 92,004 91,687 89,770
10. Cash flows netted in the cash flow statement
Half Half Year
year to year to to
30 30 31 Mar
Sep 2001 Sep 2000 2001
As As
restated restated
£000 £000 £000
Group operating profit/(loss) 2,430 (2,772) (1,352)
Depreciation charges 2,990 2,689 5,510
Amortisation of goodwill 149 (48) 100
Net profit on disposal of fixed assets 16 89 (324)
Change in stocks (5,278) (5,976) (9,556)
Change in debtors 4,179 863 (3,731)
Change in creditors (7,396) (3,697) 10,048
Change in provisions (175) (498) (2,620)
Net cash outflow from operating activities (3,085) (9,350) (1,925)
Interest received 11 118 176
Interest paid (557) (172) (608)
Net cash outflow from the servicing of finance (546) (54) (432)
Purchase of fixed assets (2,704) (2,400) (6,413)
Sale of fixed assets 2,988 410 527
Investments acquired - - (343)
Net cash inflow/(outflow) from capital 284 (1,990) (6,229)
expenditure and financial investment
Decrease in term deposits - 1,500 1,500
Increase in term loans 2,000 3,497 8,000
Net cash inflow from management of liquid 2,000 4,997 9,500
resources
Notes on the Interim Financial Statements (Continued)
11. Movement in Net Debt
As at Exchange Rate Cash movement As at
30 Sep 2001 Effect in period 31
Mar 2001
£000 £000 £000 £000
Cash at bank 3,776 (45) 2,178 1,643
and in hand
Bank overdrafts (4,223) (5) (3,099) (1,119)
Net cash (447) (50) (921) 524
Debt due within (10,856) (16) (2,000) (8,840)
one year
Net debt (11,303) (66) (2,921) (8,316)
12. Report and Accounts 2001
The comparative figures for the financial year ended 31 March 2001 are
extracted from the company's statutory accounts for that financial year. Those
accounts have been reported on by the company's auditors and delivered to the
Registrar of Companies. The report of the auditors was unqualified and did not
contain a statement under section 237 (2) or (3) of the Companies Act 1985.
Copies of the Report and Accounts 2001 are available from the Company's
registered office by applying to the Company Secretary, Oxford Instruments
plc, Old Station Way, Eynsham, Witney, Oxon, OX29 4TL. The Company is
registered in England Number 775598.